AU2001294920A1 - Chrono delivery formulations and method of use thereof - Google Patents
Chrono delivery formulations and method of use thereofInfo
- Publication number
- AU2001294920A1 AU2001294920A1 AU2001294920A AU9492001A AU2001294920A1 AU 2001294920 A1 AU2001294920 A1 AU 2001294920A1 AU 2001294920 A AU2001294920 A AU 2001294920A AU 9492001 A AU9492001 A AU 9492001A AU 2001294920 A1 AU2001294920 A1 AU 2001294920A1
- Authority
- AU
- Australia
- Prior art keywords
- delivery formulations
- chrono
- chrono delivery
- formulations
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/678,335 US6620439B1 (en) | 2000-10-03 | 2000-10-03 | Chrono delivery formulations and method of use thereof |
US09/678,335 | 2000-10-03 | ||
PCT/US2001/030627 WO2002028376A2 (en) | 2000-10-03 | 2001-10-02 | Chrono delivery formulations and method of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001294920A1 true AU2001294920A1 (en) | 2002-04-15 |
Family
ID=24722368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001294920A Abandoned AU2001294920A1 (en) | 2000-10-03 | 2001-10-02 | Chrono delivery formulations and method of use thereof |
Country Status (5)
Country | Link |
---|---|
US (2) | US6620439B1 (en) |
EP (1) | EP1322297A2 (en) |
JP (1) | JP2004528270A (en) |
AU (1) | AU2001294920A1 (en) |
WO (1) | WO2002028376A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
EP1476139B1 (en) * | 2002-02-21 | 2017-05-17 | Valeant Pharmaceuticals Luxembourg S.à.r.l. | Controlled release dosage forms |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
AU2003255874A1 (en) * | 2002-08-16 | 2004-03-03 | Orchid Health Care, A Division Of Orchid Chemicals And Pharmaceuticals Ltd. | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
ES2335008T3 (en) * | 2003-04-24 | 2010-03-18 | Jagotec Ag | COMPRESSED WITH COLORED NUCLEUS. |
JP4790597B2 (en) * | 2003-04-24 | 2011-10-12 | ヤゴテック アーゲー | Delayed release tablets with defined core geometry |
EP1479383B1 (en) * | 2003-05-20 | 2006-10-04 | Ethypharm | Oral sustained release pharmaceutical composition |
EP1680110B1 (en) * | 2003-11-04 | 2011-01-05 | Supernus Pharmaceuticals, Inc. | Once daily dosage forms of trospium |
MXPA06009054A (en) * | 2004-02-11 | 2007-04-16 | Athpharma Ltd | Chronotherapeutic compositions and methods of their use. |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
DE102004043863A1 (en) | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tablets with local and time-controlled drug release in the gastrointestinal tract |
EP2462940A1 (en) | 2004-11-02 | 2012-06-13 | Chr. Hansen A/S | Stabilized bacteriophage formulations |
US20060269475A1 (en) * | 2005-04-11 | 2006-11-30 | Ryu Wonhyoung | Multi-layer structure having a predetermined layer pattern including an agent |
CN101534808A (en) | 2005-06-27 | 2009-09-16 | 拜维尔实验室国际有限公司 | Modified-release formulations of a bupropion salt |
US11311490B2 (en) * | 2005-08-10 | 2022-04-26 | Add Advanced Drug Delivery Technologies Ltd. | Oral preparation with controlled release |
US8778395B2 (en) * | 2005-08-11 | 2014-07-15 | Andrx Labs, Llc | Diltiazem controlled release formulation and method of manufacture |
US20080076743A1 (en) | 2006-08-03 | 2008-03-27 | Nitec Pharma Ag | Delayed-Release Glucocorticoid treatment of Rheumatoid Disease |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
AR074313A1 (en) | 2008-11-11 | 2011-01-05 | Boehringer Ingelheim Int | METHOD TO TREAT OR PREVENT THROMBOSIS USING DABIGATRAN ETEXYLATE OR A SALT OF THE SAME. USE. KIT |
US20110287091A1 (en) * | 2009-01-22 | 2011-11-24 | Abbot Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
EP2391369A1 (en) * | 2009-01-26 | 2011-12-07 | Nitec Pharma AG | Delayed-release glucocorticoid treatment of asthma |
NZ582836A (en) * | 2009-01-30 | 2011-06-30 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage |
EP3167876B1 (en) * | 2012-03-15 | 2021-09-08 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
CN113197846A (en) | 2013-07-19 | 2021-08-03 | 勃林格殷格翰动物保健有限公司 | Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives |
EA034054B1 (en) | 2013-12-04 | 2019-12-23 | Бёрингер Ингельхайм Ветмедика Гмбх | Improved pharmaceutical compositions of pimobendan |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
CN114129541B (en) * | 2022-01-05 | 2023-05-30 | 南通联亚药业股份有限公司 | Diltiazem hydrochloride sustained-release capsule and preparation method and application thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0043877A1 (en) | 1980-07-14 | 1982-01-20 | Russell Richard Ferrers Wakelin | Method and apparatus for displacing fluids by means of an oscillating blade |
US4894240A (en) * | 1983-12-22 | 1990-01-16 | Elan Corporation Plc | Controlled absorption diltiazem formulation for once-daily administration |
IE56999B1 (en) | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US5336504A (en) | 1987-10-16 | 1994-08-09 | Elan Corporation, Plc | Diltiazem formulations and methods of treatment |
JP2558396B2 (en) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | Controlled release formulation |
US5286497A (en) * | 1991-05-20 | 1994-02-15 | Carderm Capital L.P. | Diltiazem formulation |
US5288505A (en) | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
US5229135A (en) | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
US5914134A (en) * | 1997-01-27 | 1999-06-22 | Wockhardt Europe Limited | Process for the pulsatile delivery of diltiazem HCL and product produced thereby |
US5788987A (en) | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
US6270805B1 (en) * | 1998-11-06 | 2001-08-07 | Andrx Pharmaceuticals, Inc. | Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
US7108866B1 (en) * | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
-
2000
- 2000-10-03 US US09/678,335 patent/US6620439B1/en not_active Expired - Lifetime
-
2001
- 2001-10-02 WO PCT/US2001/030627 patent/WO2002028376A2/en active Application Filing
- 2001-10-02 EP EP01975612A patent/EP1322297A2/en not_active Withdrawn
- 2001-10-02 JP JP2002532201A patent/JP2004528270A/en active Pending
- 2001-10-02 AU AU2001294920A patent/AU2001294920A1/en not_active Abandoned
-
2003
- 2003-04-04 US US10/406,961 patent/US6926909B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6620439B1 (en) | 2003-09-16 |
EP1322297A2 (en) | 2003-07-02 |
WO2002028376A2 (en) | 2002-04-11 |
US6926909B2 (en) | 2005-08-09 |
JP2004528270A (en) | 2004-09-16 |
WO2002028376A3 (en) | 2003-03-06 |
US20030165565A1 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294920A1 (en) | Chrono delivery formulations and method of use thereof | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
AU2001286940A1 (en) | Drug delivering prostheses and methods of use | |
AU2001233526A1 (en) | Stent delivery system and method of use | |
AU2001281344A1 (en) | Angulated stent delivery system and method of use | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
IL160853A0 (en) | Nicotine containing formulations and use thereof | |
AU2001255199A1 (en) | Ceramide derivatives and method of use | |
AU2002361060A1 (en) | Use of apple core extracts in cosmetic or pharmaceutical compositions | |
AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
AU5800399A (en) | Polish composition and method of use | |
AU2002216346A1 (en) | Cabergoline pharmaceutical compositions and methods of use thereof | |
AU2001288395A1 (en) | Method for enhanced delivery of oxybutynin and compositions thereof | |
IL211958A0 (en) | Lactone formulations and method of use | |
GB0022710D0 (en) | Dispenser and method of use | |
AU2001222986A1 (en) | Dehydroascorbic acid formulations and uses thereof | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
AU2002221273A1 (en) | Delayed and sustained release formulations and method of use thereof | |
AU2002251801A1 (en) | Composition containing hedychium extract and use thereof | |
AU2001287198A1 (en) | Dental restorative compositions and method of use thereof | |
AU2962400A (en) | Cleaner composition and method of use thereof | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU2002363800A1 (en) | Therapeutic agent composition and method of use |